The WADA International Standard for Therapeutic Use Exemptions (TUEs) will come into force on the 1st of January 2010. This means that there will be changes concerning the use of inhaled Beta-2 agonists according to the following:
1. The use of Salbutamol, provided the level in the urine is less than 1000 ng/ml (dosage guideline max. 1600 μg/24 h), and Salmeterol by inhalation do not require a TUE, but should be declared on the doping control form at the time of testing. Oral use of any beta-2 agonist (i.e. tablets, syrups) is still prohibited. Examples of Beta-2 agonists including salbutamol or salmeterol: Airomir, Atrodual, Buventol, Ipramol, Salipra, Seretide, Serevent, Ventilastin and Ventoline.
2. Other Beta-2 agonists (Formoterol and Terbutaline) require a TUE in advance. There is no longer a possibility for a Declaration of Use and a Retroactive TUE as in 2009. Examples of Beta-2 agonists including Terbutaline or Formoterol: Bricanyl, Fomeda, Foradil, Formaxa Oxis, Symbicort and Terbasmin.
Additionally WADA has reintroduced Pseudoephedrine (PSE) to the 2010 Prohibited List as a specified stimulant prohibited in-competition at a urinary threshold of 150μg/mL. Pseudoephedrine is commonly used for treating allergic nasal catarrh (flu). The established threshold levels may be reached (rarely, but possibly) by some individuals within 6-20 hours of intake of some long-lasting therapeutic formulations. Advise athletes to stop taking PSE pills at least 24 hours before competition. Pseudoephedrine products are for example: Aerinaze, Cirrus and Duact.
Starting from 2010 all TUE´s need to be sent to the IFF office 30 days in advance of the IFF Event (WFC, U19WFC, EFC & Qualifications).
The updated Anti-Doping Regulations and Guidelines for IFF Events are found on the IFF web page under Anti-doping.
Please also note that the expiry date for all ATUEs is December 31st 2009.
New WADA Doping Control Video
This catchy 5-minute video is intended to provide a general overview of the doping control process while raising awareness of the athlete’s rights and responsibilities. The video, primarily targeting young athletes and those who will be subject to doping control for the first time, outlines each of the following phases of the doping control process: athlete selection, athlete notification, sample collection, laboratory analysis, and results management.
The video is found in different languages:
– English, The Doping Control
– French, Le Contrôle du dopage pour les sportifs
– Spanish, Control Antidopaje para Atletas
– German subtitles, The Doping Control
– Russian subtitles, The Doping Control
– Portuguese subtitles, The Doping Control
